» Articles » PMID: 35933883

LncRNA MIR9-3HG Enhances LIMK1 MRNA and Protein Levels to Contribute to the Carcinogenesis of Lung Squamous Cell Carcinoma Via Sponging MiR-138-5p and Recruiting TAF15

Overview
Specialty Pathology
Date 2022 Aug 7
PMID 35933883
Authors
Affiliations
Soon will be listed here.
Abstract

The aberrantly expressed long non-coding RNAs (lncRNAs) are closely correlated with the malignant progression of cancer cells. In our study, we identified lncRNA MIR9-3 host gene (MIR9-3HG) as the research target and explored its roles in lung squamous cell carcinoma (LUSC). RT-qPCR was conducted to reveal that MIR9-3HG was observably overexpressed in LUSC cells. Functional assays encompassing colony formation, 5-ethynyl-2'-deoxyuridine (EdU) staining, transwell and flow cytometry assays and western blot detecting related proteins demonstrated that MIR9-3HG depletion hampered cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) while accelerating cell apoptosis in LUSC. Subcellular fractionation assay were performed to demonstrate that MIR9-3HG was prominently distributed in the cytoplasm of LUSC cells. Luciferase reporter, RNA-binding protein immunoprecipitation (RIP), immunofluorescence (IF), fluorescent in situ hybridization (FISH) and RNA pull down assays were implemented to confirm that MIR9-3HG modulates LIM domain kinase 1 (LIMK1) mRNA and protein levels by sequestering microRNA-138-5p (miR-138-5p) and recruiting TATA-box binding protein associated factor 15 (TAF15) protein. Taken together, our research determined that MIR9-3HG up-regulated LIMK1 mRNA and protein levels to promote LUSC carcinogenesis, which offers a novel insight into mechanisms of LUSC.

Citing Articles

Tata-box-binding protein-associated factor 15 as a new potential marker in gastrointestinal tumors.

Elpek G World J Gastroenterol. 2024; 30(28):3367-3372.

PMID: 39091718 PMC: 11290397. DOI: 10.3748/wjg.v30.i28.3367.


mA modification of lncRNA PHKA1-AS1 enhances Actinin Alpha 4 stability and promotes non-small cell lung cancer metastasis.

Guo Q, Zhang G, Zhou W, Lu Y, Chen X, Deng Z MedComm (2020). 2024; 5(6):e547.

PMID: 38764726 PMC: 11099756. DOI: 10.1002/mco2.547.


Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks.

Braga E, Fridman M, Burdennyy A, Loginov V, Dmitriev A, Pronina I Int J Mol Sci. 2023; 24(17).

PMID: 37686426 PMC: 10487663. DOI: 10.3390/ijms241713617.


5-Methylcytosine-related lncRNAs: predicting prognosis and identifying hot and cold tumor subtypes in head and neck squamous cell carcinoma.

Huang J, Xu Z, Zhou C, Cheng L, Zeng H, Shen Y World J Surg Oncol. 2023; 21(1):180.

PMID: 37312123 PMC: 10265901. DOI: 10.1186/s12957-023-03067-w.


TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor.

Guo C, Tang L, Li X, Huang L World J Gastroenterol. 2023; 29(19):2932-2949.

PMID: 37274797 PMC: 10237090. DOI: 10.3748/wjg.v29.i19.2932.